Page 17 - Britain Eakin News Today

The Federal Circuit on Friday appeared to call into question EagleView's $375 million win over a Verisk Analytics unit, suggesting its patents on technology for determining roof repair estimates through aerial imagery might be invalid under Alice.

A Federal Circuit panel on Thursday seemed inclined to agree with Intel that the threat of a future lawsuit by Qualcomm gives it standing to appeal Patent Trial and Appeal Board decisions upholding claims in two Qualcomm patents that had already been asserted in litigation against Apple.

The Federal Circuit said Friday that Western District of Texas Judge Alan Albright abused his discretion by retransferring Fintiv Inc.'s infringement suit against Apple over its mobile wallet from Austin to Waco, Texas, and ordered him to ship the case back for trial.

A Missouri federal judge on Wednesday rejected a bid by Voice Tech Corp. to enter a default judgment against artificial intelligence company Mycroft AI in a dispute over voice command patents, but did find Mycroft in contempt for reposting online content the court had previously ordered it to remove.

The Patent Trial and Appeal Board has invalidated a Swedish company's patent on an automated process for terminating over-the-counter derivative contracts under Alice and rejected a revised bid to amend the claims, handing a win to challenger Quantile Technologies Ltd.

As the America Invents Act turned 10 Thursday, two dozen independent inventors and activists gathered outside the U.S. Patent and Trademark Office in Alexandria, Virginia, to demonstrate against one of the law's major impacts: the creation of the Patent Trial and Appeal Board.

A World Trade Organization committee on Thursday met to discuss the European Union's proposal aimed at boosting global distribution of COVID-19 vaccines through easing regulatory hurdles rather than suspending intellectual property protections for the vaccines.

The European Union on Friday handed over a proposal aimed at boosting global distribution of COVID-19 vaccines by easing regulatory hurdles, but it stopped short of calling on countries to suspend intellectual property protections on the vaccines.